Amyloidosis secondary to drug abuse and chronic skin suppuration

H. Jacob, C. Charytan, J. H. Rascoff, R. Golden, R. Janis

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Amyloidosis has not been included in the wide spectrum of medical complications associated with drug abuse. Chronic visceral infection is a recognized cause of amyloidosis, but chronic suppuration of the skin is not a well-appreciated cause of this condition. Furthermore, to our knowledge, chronic skin suppuration secondary to parenteral drug abuse has not been reported as a cause for systemic amyloidosis. We report a case in which subcutaneous injections of narcotic tablets led to chronic skin suppuration and systemic amyloidosis.

Original languageEnglish (US)
Pages (from-to)1150-1151
Number of pages2
JournalArchives of Internal Medicine
Volume138
Issue number7
DOIs
StatePublished - Dec 1 1978

Fingerprint

Suppuration
Amyloidosis
Substance-Related Disorders
Skin
Intravenous Substance Abuse
Narcotics
Subcutaneous Injections
Tablets
Infection

Cite this

Amyloidosis secondary to drug abuse and chronic skin suppuration. / Jacob, H.; Charytan, C.; Rascoff, J. H.; Golden, R.; Janis, R.

In: Archives of Internal Medicine, Vol. 138, No. 7, 01.12.1978, p. 1150-1151.

Research output: Contribution to journalArticle

Jacob, H. ; Charytan, C. ; Rascoff, J. H. ; Golden, R. ; Janis, R. / Amyloidosis secondary to drug abuse and chronic skin suppuration. In: Archives of Internal Medicine. 1978 ; Vol. 138, No. 7. pp. 1150-1151.
@article{536052f15c6e437eab8b65bbd0953ff0,
title = "Amyloidosis secondary to drug abuse and chronic skin suppuration",
abstract = "Amyloidosis has not been included in the wide spectrum of medical complications associated with drug abuse. Chronic visceral infection is a recognized cause of amyloidosis, but chronic suppuration of the skin is not a well-appreciated cause of this condition. Furthermore, to our knowledge, chronic skin suppuration secondary to parenteral drug abuse has not been reported as a cause for systemic amyloidosis. We report a case in which subcutaneous injections of narcotic tablets led to chronic skin suppuration and systemic amyloidosis.",
author = "H. Jacob and C. Charytan and Rascoff, {J. H.} and R. Golden and R. Janis",
year = "1978",
month = "12",
day = "1",
doi = "10.1001/archinte.138.7.1150",
language = "English (US)",
volume = "138",
pages = "1150--1151",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Amyloidosis secondary to drug abuse and chronic skin suppuration

AU - Jacob, H.

AU - Charytan, C.

AU - Rascoff, J. H.

AU - Golden, R.

AU - Janis, R.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - Amyloidosis has not been included in the wide spectrum of medical complications associated with drug abuse. Chronic visceral infection is a recognized cause of amyloidosis, but chronic suppuration of the skin is not a well-appreciated cause of this condition. Furthermore, to our knowledge, chronic skin suppuration secondary to parenteral drug abuse has not been reported as a cause for systemic amyloidosis. We report a case in which subcutaneous injections of narcotic tablets led to chronic skin suppuration and systemic amyloidosis.

AB - Amyloidosis has not been included in the wide spectrum of medical complications associated with drug abuse. Chronic visceral infection is a recognized cause of amyloidosis, but chronic suppuration of the skin is not a well-appreciated cause of this condition. Furthermore, to our knowledge, chronic skin suppuration secondary to parenteral drug abuse has not been reported as a cause for systemic amyloidosis. We report a case in which subcutaneous injections of narcotic tablets led to chronic skin suppuration and systemic amyloidosis.

UR - http://www.scopus.com/inward/record.url?scp=0018207634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018207634&partnerID=8YFLogxK

U2 - 10.1001/archinte.138.7.1150

DO - 10.1001/archinte.138.7.1150

M3 - Article

VL - 138

SP - 1150

EP - 1151

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 7

ER -